Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post -Transplant

Grant

Date/time Interval

  • September 1, 2019 - August 31, 2022

    • Awarded By

    Total Award Amount

  • 90000.00

    • Direct Costs

  • 60606.00

    • Sponsor Award Id

  • N006814115

    • Contributor

  • Daniel Feig   Investigator  
  • Michael Seifert   Principal Investigator